RELPAX Safety Questions, RELPAX Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about RELPAX. Our extensive database of RELPAX adverse events and RELPAX warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about RELPAX
RELPAX Safety Reports
Total RELPAX reports: 65.RELPAX FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 17.
Take RELPAX Side Effects Survey or Share Your RELPAX Story. RELPAX Usage.
Physician from UNITED STATES reported RELPAX problem on Jan 12, 2007. Female patient, weighting 248.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: convulsion, head injury, migraine. RELPAX dosage: unknown. During the same period patient was treated with TOPAMAX, LEXAPRO, METFORMIN. Patient recovered.
RELPAX problem was reported by a Pharmacist from FRANCE on Jan 17, 2007. Female patient, 66 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, migraine. RELPAX dosage: unknown. Patient recovered.
Physician from FRANCE reported RELPAX problem on Feb 09, 2007. Female patient, weighting 123.5 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: headache. RELPAX dosage: unknown. During the same period patient was treated with GINKGO BILOBA, ATORVASTATIN, PROPRANOLOL HYDROCHLORIDE. Patient recovered.
RELPAX problem was reported by a Physician from UNITED STATES on Feb 21, 2007. Female patient, weighting 248.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: convulsion, head injury, migraine. RELPAX dosage: unknown. During the same period patient was treated with TOPAMAX, LEXAPRO, METFORMIN. Patient recovered.
Physician from JAPAN reported RELPAX problem on Mar 06, 2007. Female patient, 34 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: cerebral infarction. RELPAX dosage: DAILY DOSE:20MG. Patient was hospitalized. Patient recovered.
RELPAX problem was reported by a Physician from UNITED STATES on Mar 05, 2007. Male patient, 44 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: angiopathy, cardiac arrest. RELPAX dosage: unknown. During the same period patient was treated with IMITREX. Patient was hospitalized. Patient died on 03/05/2007.
Physician from UNITED STATES reported RELPAX problem on Mar 12, 2007. Female patient, 50 years of age, weighting 100.1 lb, was diagnosed with migraine, headache, migraine with aura and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: arthralgia, joint stiffness, salivary gland enlargement. RELPAX dosage: unknown. Patient recovered.
RELPAX problem was reported by a Physician from FRANCE on Mar 14, 2007. Female patient, 30 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: angioedema. RELPAX dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported RELPAX problem on Mar 14, 2007. Female patient, 49 years of age, weighting 123.5 lb, was diagnosed with adenoma benign and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. RELPAX dosage: unknown. During the same period patient was treated with DOSTINEX. Patient was hospitalized. Patient recovered.
RELPAX problem was reported by a Physician from AUSTRIA on Mar 15, 2007. Female patient, 44 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: hordeolum. RELPAX dosage: unknown. Patient recovered.
Physician from UNITED STATES reported RELPAX problem on Jan 24, 2006. Female patient, 55 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. RELPAX dosage: (40 MG). During the same period patient was treated with METFORMIN, GLUCOTROL. Patient was hospitalized. Patient recovered.
RELPAX problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 21, 2006. Female patient, 49 years of age, was diagnosed with ill-defined disorder and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: blood pressure. RELPAX dosage: (40 MG. During the same period patient was treated with PROPRANOLOL, ALLEGRA, DIOVAN. Patient recovered.
Physician from UNITED STATES reported RELPAX problem on May 02, 2006. Female patient, 42 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: insulin resistance, menstrual disorder, myocardial infarction. RELPAX dosage: (40 MG). During the same period patient was treated with WELCHOL, METFORMIN. Patient was hospitalized. Patient recovered.
RELPAX problem was reported by a Health Professional from UNITED STATES on Sept 11, 2006. Male patient, 27 years of age, weighting 292.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: musculoskeletal stiffness, nausea, pain. RELPAX dosage: (40 MG), ORAL. During the same period patient was treated with ZYRTEC. Patient recovered.
Physician from UNITED STATES reported RELPAX problem on Sept 11, 2006. Male patient, 48 years of age, weighting 140.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: muscle tightness, tension headache, throat tightness. RELPAX dosage: 40 MG (20 MG). Patient recovered.
RELPAX problem was reported by a Physician from UNITED STATES on Aug 17, 2006. Male patient was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: throat tightness. RELPAX dosage: 40 MG (40 MG, 1 IN 1 D). Patient recovered.
Health Professional from UNITED STATES reported RELPAX problem on Oct 09, 2006. Male patient, 49 years of age, weighting 144.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: anxiety, chest pain, dyspnoea, hypertension, hypotension, myalgia, palpitations, pharyngolaryngeal pain, pyrexia. RELPAX dosage: (40 MG, FREQUENCY: PRN), ORAL. Patient recovered.
RELPAX problem was reported by a Health Professional from UNITED STATES on Nov 08, 2006. Female patient, 42 years of age, was diagnosed with headache, migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, chest discomfort. RELPAX dosage: unknown. Patient recovered.
Physician from UNITED STATES reported RELPAX problem on Oct 13, 2006. Female patient, 26 years of age, was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. RELPAX dosage: unknown. Patient was hospitalized. Patient recovered.
RELPAX problem was reported by a Pharmacist from FRANCE on Mar 22, 2007. Male patient, weighting 154.3 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: dependence, incorrect dose administered, migraine. RELPAX dosage: unknown. During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM, TAMSULOSIN, FLUTICASONE PROPIONATE, FENOTEROL. Patient recovered.
Physician from FRANCE reported RELPAX problem on Mar 26, 2007. Female patient, 25 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: thrombosis. RELPAX dosage: unknown. Patient was hospitalized. Patient recovered.
RELPAX problem was reported by a Physician from UNITED STATES on Mar 28, 2007. Male patient, 19 years of age, was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: cerebral thrombosis, headache, parosmia. RELPAX dosage: unknown. Patient recovered.
Physician from UNITED STATES reported RELPAX problem on Apr 04, 2007. Female patient, weighting 117.1 lb, was diagnosed with migraine, headache, glaucoma and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, antinuclear antibody positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, granulomatous liver disease, smooth muscle antibody. RELPAX dosage: unknown. During the same period patient was treated with NAPROXEN, TRIVITAN. Patient recovered.
RELPAX problem was reported by a Physician from JAPAN on Apr 10, 2007. Female patient, 34 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction. RELPAX dosage: DAILY DOSE:20MG. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported RELPAX problem on Apr 17, 2007. Female patient, 42 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: chest pain, meningeal disorder. RELPAX dosage: unknown. Patient recovered.
RELPAX problem was reported by a Physician from JAPAN on Apr 24, 2007. Female patient, 34 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction. RELPAX dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported RELPAX problem on May 03, 2007. Female patient, weighting 110.2 lb, was diagnosed with migraine without aura, hypotension and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: accommodation disorder, ageusia, aggression, amnesia, anxiety, aphasia, asthenia, balance disorder, cerebral ischaemia. RELPAX dosage: DAILY DOSE:80MG-FREQ:PRN. During the same period patient was treated with GINKO BILOBA. Patient recovered.
RELPAX problem was reported by a Physician from JAPAN on May 22, 2007. Female patient, 25 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: haemorrhage subcutaneous. RELPAX dosage: DAILY DOSE:40MG. Patient recovered.
Physician from UNITED STATES reported RELPAX problem on May 29, 2007. Female patient was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, eye swelling, throat tightness. RELPAX dosage: DAILY DOSE:40MG. Patient recovered.
RELPAX problem was reported by a Physician from AUSTRIA on May 31, 2007. Female patient, weighting 154.3 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: micturition disorder, migraine. RELPAX dosage: unknown. During the same period patient was treated with PASPERTIN, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
Physician from MOROCCO reported RELPAX problem on June 15, 2007. Female patient, 40 years of age, weighting 154.3 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: orthostatic hypotension, syncope. RELPAX dosage: unknown. Patient recovered.
RELPAX problem was reported by a Physician from UNITED STATES on June 19, 2007. Female patient, weighting 119.9 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, eye swelling, speech disorder, throat tightness. RELPAX dosage: DAILY DOSE:40MG. Patient recovered.
Consumer or non-health professional from FRANCE reported RELPAX problem on June 15, 2007. Female patient, weighting 110.2 lb, was diagnosed with migraine without aura, hypotension and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: accommodation disorder, ageusia, aggression, amnesia, anxiety, aphasia, asthenia, balance disorder, cerebral ischaemia. RELPAX dosage: DAILY DOSE:80MG-FREQ:PRN. During the same period patient was treated with GINKO BILOBA. Patient recovered.
RELPAX problem was reported by a Physician from JAPAN on July 03, 2006. Female patient, 39 years of age, weighting 121.3 lb, was diagnosed with migraine with aura and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: respiratory distress, sinus arrhythmia, throat tightness. RELPAX dosage: 20 MG (AS NECESSARY), ORAL. During the same period patient was treated with DOMPERIDONE, TIZANIDINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from NETHERLANDS reported RELPAX problem on July 13, 2006. Female patient, 32 years of age, weighting 149.9 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: lymphoma, sleep disorder, stress. RELPAX dosage: 40 MG AS NECESSARY, ORAL. During the same period patient was treated with VALERIAN. Patient recovered.
RELPAX problem was reported by a Physician from DENMARK on July 13, 2006. Male patient, 72 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: depression, dysphonia, refusal of treatment by patient. RELPAX dosage: 40 MG (40 MG, 1 IN 1 TOTAL), ORAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RELPAX problem on July 19, 2006. Female patient, 46 years of age, weighting 170.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, pharyngeal oedema, vomiting. RELPAX dosage: 40 MG AS NECESSARY, ORAL. During the same period patient was treated with CRESTOR. Patient recovered.
RELPAX problem was reported by a Consumer or non-health professional from SWITZERLAND on July 11, 2006. Female patient was diagnosed with headache and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: condition aggravated, headache. RELPAX dosage: (40 MG), ORAL. Patient recovered.
Pharmacist from FRANCE reported RELPAX problem on July 20, 2006. Female patient, 42 years of age, weighting 110.2 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: condition aggravated, migraine. RELPAX dosage: 40 MG, ONCE DAILY AS NECESSARY. Patient recovered.
RELPAX problem was reported by a Consumer or non-health professional from SWITZERLAND on Aug 07, 2006. Female patient, 28 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: binge eating, dizziness, fatigue, hypotonia, impaired driving ability. RELPAX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RELPAX problem on Aug 12, 2006. Female patient, 53 years of age, weighting 170.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: disorientation, dysstasia, headache, insomnia, migraine. RELPAX dosage: 40 MG. During the same period patient was treated with BENADRYL, VICODIN ES. Patient recovered.
RELPAX problem was reported by a Physician from DENMARK on Aug 17, 2006. Male patient, 72 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: depression, dysphonia. RELPAX dosage: 40 MG (40 MG, 1 IN 1 TOTAL) ORAL. Patient recovered.
Physician from DENMARK reported RELPAX problem on Aug 17, 2006. Male patient, 72 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: depression, dysphonia, economic problem, headache. RELPAX dosage: 40 MG (40 MG, 1 IN 1 TOTAL), ORAL. Patient recovered.
RELPAX problem was reported by a Pharmacist from JAPAN on Sept 11, 2006. Female patient was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: gastric haemorrhage. RELPAX dosage: unknown. Patient recovered.
Physician from FRANCE reported RELPAX problem on Sept 11, 2006. Female patient, 56 years of age, was diagnosed with headache and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: headache. RELPAX dosage: unknown. Patient was hospitalized. Patient recovered.
RELPAX problem was reported by a Physician from FRANCE on Sept 15, 2006. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with migraine without aura and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: accommodation disorder, affective disorder, aggression, anxiety, aphasia, arterial spasm, asthenia, back pain, balance disorder. RELPAX dosage: 80 MG (PRN). During the same period patient was treated with GINKO BILOBA. Patient recovered.
Consumer or non-health professional from GERMANY reported RELPAX problem on Sept 29, 2006. Female patient, 43 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, hypoaesthesia, tachycardia. RELPAX dosage: 40 MG (20 MG, 2 IN 1 D), ORAL. Patient recovered.
RELPAX problem was reported by a Physician from SWITZERLAND on Oct 06, 2006. Female patient, 28 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: binge eating, depressed level of consciousness, disturbance in attention, dizziness, fatigue, hypotonia. RELPAX dosage: (40 MG, 1 IN 2 WK), ORAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RELPAX problem on Oct 13, 2006. Female patient, 53 years of age, weighting 170.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: disorientation, dysstasia, insomnia, mental impairment, migraine. RELPAX dosage: (40 MG). During the same period patient was treated with BENADRYL, VICODIN ES. Patient recovered.
RELPAX problem was reported by a Physician from CANADA on Oct 18, 2006. Female patient was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: retinal tear. RELPAX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RELPAX problem on Oct 21, 2006. Female patient, 39 years of age, weighting 250.0 lb, was diagnosed with migraine, contraception and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, pulmonary embolism. RELPAX dosage: 40MG (AS NECESSARY). During the same period patient was treated with ORTHO CYCLEN, TOPAMAX, VERAPAMIL. Patient was hospitalized. Patient recovered.
RELPAX problem was reported by a Physician from ITALY on Oct 24, 2006. Male patient, 35 years of age, was diagnosed with headache and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: coma. RELPAX dosage: 40 MG (20 MG,2 IN 1 D), ORAL. Patient recovered.
Physician from FRANCE reported RELPAX problem on Oct 04, 2006. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with migraine without aura, hypotension and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: accident, accommodation disorder, affective disorder, aggression, anxiety, cerebral ischaemia, clumsiness, contusion, diarrhoea. RELPAX dosage: 80 MG, (PRN). During the same period patient was treated with GINKO BILOBA. Patient recovered.
RELPAX problem was reported by a Consumer or non-health professional from GERMANY on Nov 16, 2006. Female patient, 43 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: agitation, blood pressure increased, hypoaesthesia, tachycardia. RELPAX dosage: 40 MG (20 MG, 2 IN 1 D), ORAL. During the same period patient was treated with PANTOZOL. Patient recovered.
Physician from UNITED STATES reported RELPAX problem on Nov 22, 2006. Female patient, 48 years of age, was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: abasia, abdominal pain, asthenia, hypertension. RELPAX dosage: unknown. Patient recovered.
RELPAX problem was reported by a Physician from FRANCE on Dec 15, 2006. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with migraine without aura, hypotension and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: abasia, abnormal behaviour, affective disorder, ageusia, aggression, anxiety, aphasia, asthenia, balance disorder. RELPAX dosage: 80 MG (PRN),. During the same period patient was treated with GINKO BILOBA. Patient recovered.
Physician from UNITED STATES reported RELPAX problem on June 28, 2007. Male patient, 82 years of age, was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: amnesia, dementia alzheimer's type. RELPAX dosage: unknown. Patient recovered.
RELPAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 08, 2007. Female patient, weighting 250.0 lb, was diagnosed with benign intracranial hypertension, blood pressure and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: eye pruritus, eye swelling, lip swelling, skin disorder. RELPAX dosage: unknown. During the same period patient was treated with ATENOLOL, TOPAMAX, DIAMOX. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RELPAX problem on July 11, 2007. Female patient, weighting 152.3 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: gait disturbance, headache, mutism, photophobia, speech disorder, vomiting. RELPAX dosage: unknown. During the same period patient was treated with EXCEDRIN. Patient recovered.
RELPAX problem was reported by a Physician from FRANCE on July 26, 2007. Female patient, weighting 165.3 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: chest pain, meningeal disorder. RELPAX dosage: unknown. During the same period patient was treated with DOLIPRANE. Patient recovered.
Physician from UNITED STATES reported RELPAX problem on July 26, 2007. Female patient, 44 years of age, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, cardiomyopathy. RELPAX dosage: unknown. During the same period patient was treated with AMERGE, IMITREX, AXERT, FROVA. Patient was hospitalized. Patient recovered.
RELPAX problem was reported by a Pharmacist from FRANCE on July 27, 2007. Female patient, weighting 187.4 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: headache, overdose. RELPAX dosage: unknown. During the same period patient was treated with ANALGESICS, LAMALINE, PROPOFOL, NARAMIG. Patient recovered.
Consumer or non-health professional from MEXICO reported RELPAX problem on July 26, 2007. Female patient, weighting 156.5 lb, was diagnosed with headache and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: dry mouth, hypersensitivity, nausea, pain, paraesthesia. RELPAX dosage: unknown. During the same period patient was treated with TEMPRA. Patient recovered.
RELPAX problem was reported by a Pharmacist from UNITED STATES on Aug 15, 2007. Female patient, weighting 117.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cerebral hypoperfusion, cerebral vasoconstriction, confusional state, disorientation, vomiting. RELPAX dosage: 40MG PO. During the same period patient was treated with INDERAL, LEVOTHYROXINE, ESTRADIOL, DICYCLOMINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported RELPAX problem on Sept 10, 2007. Female patient, 27 years of age, weighting 115.0 lb, was diagnosed with migraine and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: bone neoplasm. RELPAX dosage: unknown. Patient was hospitalized. Patient recovered.
This
drug has an active FDA Safety Alert